Mirum Pharmaceuticals, Inc. MIRM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s short-term investments?
- Mirum Pharmaceuticals, Inc. (MIRM) reported short-term investments of $61.35M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s short-term investments decreased by 6.8% year-over-year, from $65.85M to $61.35M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s short-term investments has grown at a -0.7% compound annual growth rate (CAGR), from $89.73M to $86.64M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.